Stanford researchers find cancer “vaccine”

Stanford researchers find cancer “vaccine”
Ronald Levy (left) and Idit Sagiv-Barfi led the work on a possible cancer treatment that involves injecting two immune-stimulating agents directly into solid tumors.

Stanford University researchers may have just found a way to completely eliminate Lymphoma in cancer patients.

In a recent study conducted by Professor of Oncology Ronald Levy, MD and Idit Sagiv-Barfi, PhD, cancer ridden mice were completely cured of their disease.

Levy’s method works to reactivate the cancer-specific T cells (immune cells meant to maintain cell division) by injecting microgram amounts of two agents directly into the tumor site.

The injections were nothing more than minute amounts of two immune-stimulating agents. These agents were injected directly into solid tumors in the mice which then eliminated all traces of cancer in the animals, including distant, untreated metastases (secondary malignant growths).

The study also found that the treatment works for many different types of cancer, including those that arise spontaneously.

One of the immune-stimulating agents is currently approved for use in humans; the other has been tested for human use in several unrelated clinical trials. A clinical trial was launched in January to test the effect of the treatment in patients with lymphoma.

This study not only offers promising results that can be used in further cancer research, but it also could potentially be a massive breakthrough in medical practices and cancer specific medicine.

Read the full release from the study here.